Singapore markets open in 7 hours 9 minutes

Straits Times Index
3,296.89
+4.20(+0.13%)
S&P 500
5,053.94
+35.55(+0.71%)
Dow
38,164.43
+261.14(+0.69%)
Nasdaq
15,791.81
+186.33(+1.19%)
Bitcoin USD
59,045.16
+1,827.04(+3.19%)
CMC Crypto 200
1,273.70
+2.95(+0.23%)

Theravance Biopharma, Inc. (TBPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

9.15

+0.31

(+3.51%)

As of 01:50PM EDT. Market open.

Trade prices are not sourced from all markets

Press releases

PR Newswire
Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm ET (2:00 pm PT/10:00 pm IST) that day.
PR Newswire
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024
Theravance Biopharma, Inc. (the "Company") (NASDAQ: TBPH) today announced it will host a virtual KOL event on Thursday, May 23, 2024 from 10:00 AM to 11:30 AM ET, featuring Horacio Kaufmann, MD, FAAN (Felicia B. Axelrod Professor of Neurology and Professor of Medicine at New York University Grossman School of Medicine) and Italo Biaggioni, MD (Professor of Medicine and Pharmacology Director, Vanderbilt Autonomic Dysfunction Center), who will discuss the unmet need and current treatment landscape
PR Newswire
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced financial and operational results for the fourth quarter of 2023 and full-year ended December 31, 2023.